Preoperatively Misclassified, Surgically Removed Benign Renal Masses: A Systematic Review of Surgical Series and United States Population Level Burden Estimate

医学 小教堂 人口 南卡罗来纳州 老年学 历史 艺术史 政治学 公共行政 环境卫生
作者
David C. Johnson,Josip Vukina,Angela Smith,Anne-Marie Meyer,Stephanie B. Wheeler,Tzy-Mey Kuo,Hung-Jui Tan,Michael Woods,Mathew Raynor,Eric Wallen,Raj S. Pruthi,Matthew E. Nielsen
出处
期刊:The Journal of Urology [Lippincott Williams & Wilkins]
卷期号:193 (1): 30-35 被引量:206
标识
DOI:10.1016/j.juro.2014.07.102
摘要

No AccessJournal of UrologyAdult Urology1 Jan 2015Preoperatively Misclassified, Surgically Removed Benign Renal Masses: A Systematic Review of Surgical Series and United States Population Level Burden Estimate David C. Johnson, Josip Vukina, Angela B. Smith, Anne-Marie Meyer, Stephanie B. Wheeler, Tzy-Mey Kuo, Hung-Jui Tan, Michael E. Woods, Mathew C. Raynor, Eric M. Wallen, Raj S. Pruthi, and Matthew E. Nielsen David C. JohnsonDavid C. Johnson Department of Urology, University of North Carolina, Chapel Hill, North Carolina , Josip VukinaJosip Vukina Department of Urology, University of North Carolina, Chapel Hill, North Carolina , Angela B. SmithAngela B. Smith Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , Anne-Marie MeyerAnne-Marie Meyer Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , Stephanie B. WheelerStephanie B. Wheeler Department of Health Policy and Management, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , Tzy-Mey KuoTzy-Mey Kuo Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , Hung-Jui TanHung-Jui Tan Department of Urology, Robert Wood Johnson Clinical Scholars Program, University of California-Los Angeles, Los Angeles, California , Michael E. WoodsMichael E. Woods Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , Mathew C. RaynorMathew C. Raynor Department of Urology, University of North Carolina, Chapel Hill, North Carolina , Eric M. WallenEric M. Wallen Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , Raj S. PruthiRaj S. Pruthi Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , and Matthew E. NielsenMatthew E. Nielsen University of North Carolina, Chapel Hill, North Carolina View All Author Informationhttps://doi.org/10.1016/j.juro.2014.07.102AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: A significant proportion of renal masses removed for suspected malignancy are histologically benign with the probability inversely proportional to lesion size. To our knowledge the number of preoperatively misclassified benign renal masses treated with nephrectomy is currently unknown. Given the increasing incidence and decreasing average size of renal cell carcinoma, this burden is likely increasing. We estimated the population level burden of surgically removed, preoperatively misclassified benign renal masses in the United States. Materials and Methods: We systematically reviewed the literature for studies of pathological findings of renal masses removed for suspected renal cell carcinoma based on preoperative imaging through July 1, 2014. We excluded studies that did not describe benign pathology and with masses not stratified by size, and in which pathology results were based on biopsy. SEER data were queried for the incidence of surgically removed renal cell carcinomas in 2000 to 2009. Results: A total of 19 studies of tumor pathology based on size met criteria for review. Pooled estimates of the proportion of benign histology in our primary analysis (American studies only and 1 cm increments) were 40.4%, 20.9%, 19.6%, 17.2%, 9.2% and 6.4% for tumors less than 1, 1 to less than 2, 2 to less than 3, 3 to less than 4, 4 to 7 and greater than 7, respectively. The estimated number of surgically resected benign renal masses in the United States from 2000 to 2009 increased by 82% from 3,098 to 5,624. Conclusions: These estimates suggest that the population level burden of preoperatively misclassified benign renal masses is substantial and increasing rapidly, paralleling increases in surgically resected small renal cell carcinoma. This study illustrates an important and to our knowledge previously unstudied dimension of overtreatment that is not directly quantified in contemporary surveillance data. References 1 SEER Cancer Statistics Review, 1975–2007, updated 2010. Available at http://seer.cancer.gov/csr/1975_2007/. Accessed July 22, 2014. Google Scholar 2 : Rising incidence of renal cell cancer in the United States. JAMA1999; 281: 1628. Crossref, Medline, Google Scholar 3 : Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol2002; 167: 57. Link, Google Scholar 4 : Utilization of radiology services in the United States: levels and trends in modalities, regions, and populations. Radiology2005; 234: 824. Google Scholar 5 : Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst2006; 98: 1331. Google Scholar 6 : Increased incidence of serendipitously discovered renal cell carcinoma. Urology1998; 51: 203. Crossref, Medline, Google Scholar 7 : Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol2000; 163: 426. Link, Google Scholar 8 : The evolving presentation of renal carcinoma in the united states: trends from the surveillance, epidemiology, and end results program. J Urol2006; 176: 2397. Link, Google Scholar 9 : Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the national cancer data base, 1993 to 2004. J Urol2008; 179: 2131. Link, Google Scholar 10 : Renal cell cancer stage migration: Analysis of the national cancer data base. Cancer2008; 113: 78. Google Scholar 11 : Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality. J Urol2009; 181: 1020. Link, Google Scholar 12 : Overdiagnosis in cancer. J Natl Cancer Inst2010; 102: 605. Google Scholar 13 : Guideline for management of the clinical stage T1 renal mass. J Urol2009; 182: 1271. Link, Google Scholar 14 : EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol2010; 58: 398. Google Scholar 15 : NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw2009; 7: 618. Google Scholar 16 : Solid renal tumors: an analysis of pathological features related to tumor size. J Urol2003; 170: 2217. Link, Google Scholar 17 Surveillance, Epidemiology, and End Results Program: Cancer Statistics Review, 1975-2009. Based on November 2011 SEER data submission, released April 2012. Available at http://seer.cancer.gov/csr/1975_2009. Accessed July 22, 2014. Google Scholar 18 : Histopathology of surgically managed renal tumors: analysis of a contemporary series. Urology2003; 62: 827. Google Scholar 19 : Pathological features of renal neoplasms classified by size and symptomatology. J Urol2006; 176: 1317. Link, Google Scholar 20 : Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology2006; 68: 737. Google Scholar 21 : Frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients. J Endourol2007; 21: 819. Google Scholar 22 : Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades. Urology2009; 73: 1293. Google Scholar 23 : Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol2009; 181: 2033. Link, Google Scholar 24 : Clinical predictors of renal mass pathological features. BJU Int2011; 107: 735. Google Scholar 25 : Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol2007; 178: 414. Link, Google Scholar 26 : Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology2008; 72: 598. Google Scholar 27 : Prognostic variables to predict cancer-related death in incidental renal tumours. BJU Int2008; 102: 1376. Google Scholar 28 : Incidence of benign lesions according to tumor size in solid renal masses. Int Braz J Urol2009; 35: 427. Google Scholar 29 : A multi-institutional study on histopathological characteristics of surgically treated renal tumors: the importance of tumor size. Yonsei Med J2008; 49: 639. Google Scholar 30 : A decade of surgically removed small renal masses in the Netherlands: characteristics and trends in type of surgery and pathologic reporting. J Endourol2010; 24: 1675. Google Scholar © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byButaney M, Wilder S, Patel A, Qi J, Mirza M, Noyes S, Johnson A, Van Til M, Jafri S, Ginsburg K, Rogers C and Lane B (2023) Initial Management of Indeterminate Renal Lesions in a Statewide Collaborative: A MUSIC-KIDNEY AnalysisJournal of Urology, VOL. 210, NO. 1, (79-87), Online publication date: 1-Jul-2023.Su Z, Patel H, Huang M, Alam R, Cheaib J, Pavlovich C, Allaf M and Pierorazio P (2022) Active Surveillance versus Immediate Intervention for Small Renal Masses: A Cost-Effectiveness and Clinical Decision AnalysisJournal of Urology, VOL. 208, NO. 4, (794-803), Online publication date: 1-Oct-2022.Uhlig A, Lenis A, Wang X and Shuch B (2021) Sequencing of Renal Mass Biopsy and Ablation: Results from the National Cancer DatabaseUrology Practice, VOL. 8, NO. 5, (555-564), Online publication date: 1-Sep-2021.Laguna M (2019) Re: Diagnostic Needle Biopsies in Renal Masses: Patient and Physician PerspectivesJournal of Urology, VOL. 202, NO. 1, (28-29), Online publication date: 1-Jul-2019.Laguna M (2018) Re: Diagnostic Performance and Interreader Agreement of a Standardized MR Imaging Approach in the Prediction of Small Renal Mass HistologyJournal of Urology, VOL. 200, NO. 6, (1161-1162), Online publication date: 1-Dec-2018.Zhao C, Tolkach Y, Schmidt D, Kristiansen G, Müller S and Ellinger J (2017) 5′-tRNA Halves are Dysregulated in Clear Cell Renal Cell CarcinomaJournal of Urology, VOL. 199, NO. 2, (378-383), Online publication date: 1-Feb-2018.Wolf J (2017) Biopsy of Small Renal Masses Should be Routinely Performed before Deciding TreatmentJournal of Urology, VOL. 198, NO. 4, (757-759), Online publication date: 1-Oct-2017.Laviana A, Kundavaram C, Tan H, Burke M, Niedzwiecki D, Lee R and Hu J (2016) Determining the True Costs of Treating Small Renal Masses Using Time Driven, Activity Based CostingUrology Practice, VOL. 3, NO. 3, (180-186), Online publication date: 1-May-2016.Patel H, Johnson M, Pierorazio P, Sozio S, Sharma R, Iyoha E, Bass E and Allaf M (2016) Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the LiteratureJournal of Urology, VOL. 195, NO. 5, (1340-1347), Online publication date: 1-May-2016. Volume 193 Issue 1 January 2015 Page: 30-35 Supplementary Materials Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.Keywordskidneycarcinomarenal cellneoplasmsdiagnostic errorsSEER programAcknowledgmentsMickey Kalavsky assisted with the figures. Karen Crowell assisted with the literature review.Metrics Author Information David C. Johnson Department of Urology, University of North Carolina, Chapel Hill, North Carolina More articles by this author Josip Vukina Department of Urology, University of North Carolina, Chapel Hill, North Carolina More articles by this author Angela B. Smith Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina More articles by this author Anne-Marie Meyer Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina More articles by this author Stephanie B. Wheeler Department of Health Policy and Management, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina More articles by this author Tzy-Mey Kuo Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina More articles by this author Hung-Jui Tan Department of Urology, Robert Wood Johnson Clinical Scholars Program, University of California-Los Angeles, Los Angeles, California More articles by this author Michael E. Woods Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina Financial interest and/or other relationship with LBS LabCorp. More articles by this author Mathew C. Raynor Department of Urology, University of North Carolina, Chapel Hill, North Carolina Financial interest and/or other relationship with Intuitive Surgical and Teleflex Medical. More articles by this author Eric M. Wallen Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina More articles by this author Raj S. Pruthi Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina More articles by this author Matthew E. Nielsen University of North Carolina, Chapel Hill, North Carolina Financial interest and/or other relationship with Best Doctors and American College of Physicians. More articles by this author Expand All Advertisement PDF downloadLoading ...
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
orixero应助钙离子采纳,获得10
刚刚
ctt-22-1-18完成签到,获得积分10
刚刚
lz完成签到,获得积分10
1秒前
搞怪莫茗发布了新的文献求助10
1秒前
善学以致用应助wgr采纳,获得10
1秒前
smf960417发布了新的文献求助10
2秒前
2秒前
2秒前
2秒前
3秒前
3秒前
Owen应助cslghe采纳,获得10
3秒前
今后应助奋斗的小彭采纳,获得10
3秒前
玛卡巴卡发布了新的文献求助10
4秒前
4秒前
懦弱的吐司完成签到 ,获得积分10
4秒前
开朗熊猫完成签到,获得积分10
4秒前
清澈的湖发布了新的文献求助10
5秒前
6秒前
Costing完成签到 ,获得积分10
7秒前
宇星发布了新的文献求助20
7秒前
TingtingGZ发布了新的文献求助10
8秒前
所所应助梦锂铧采纳,获得10
9秒前
hjb发布了新的文献求助10
9秒前
小二郎应助夕瑶源采纳,获得10
9秒前
10秒前
Yangjin完成签到,获得积分10
10秒前
量子星尘发布了新的文献求助10
10秒前
11秒前
11秒前
情怀应助开朗熊猫采纳,获得10
11秒前
11秒前
大气的硬币完成签到,获得积分10
11秒前
朴素代秋发布了新的文献求助10
11秒前
smf960417完成签到,获得积分10
12秒前
12秒前
12秒前
秋刀鱼不过期完成签到,获得积分10
13秒前
花心的小白菜完成签到,获得积分10
13秒前
Lucas应助MrRen采纳,获得10
14秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Effective Learning and Mental Wellbeing 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975986
求助须知:如何正确求助?哪些是违规求助? 3520289
关于积分的说明 11202025
捐赠科研通 3256778
什么是DOI,文献DOI怎么找? 1798453
邀请新用户注册赠送积分活动 877605
科研通“疑难数据库(出版商)”最低求助积分说明 806482